Predicting the liver histology in chronic hepatitis C: How good is the clinician?

American Journal of Gastroenterology

Volumn 96, Issue 11, 2001, Pages 3165-3174

  Romagnuolo, Joseph ^b   Jhangri, Gian S ^b   Jewell, Laurence D ^b   Bain, Vincent G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC HEPATITIS; FEMALE; HEMOCHROMATOSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HYPOALBUMINEMIA; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; THROMBOCYTOPENIA;

ADULT; BIOPSY; CLINICAL COMPETENCE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MULTIVARIATE ANALYSIS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS;

EID: 0035190896     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03837-0     Document Type: Article

References (33)

1. Meta analysis of interferon randomized trial in the treatment of viral hepatitis: Effects of dose and duration
2. Randomized trial of interferon α-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
3. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
4. Liver biopsy is a useful predictor of response to interferon (IFN)-therapy in chronic hepatitis C (CHC)
5. Value of liver biopsy prior to interferon therapy for chronic viral hepatitis
6. Management of Hepatitis C: A national survey of gastroenterologists and hepatologists
7. A 21-year experience with major hemorrhage after percutaneous liver biopsy
8. The role of liver biopsy in hepatitis C
9. Histological classification and quantification of the severity of chronic hepatitis: Keep it simple!
10. An evidence-based approach to gastroenterology diagnosis
11. Model building strategies
12. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
13. Grading and staging the histopathological lesions of chronic hepatitis: The Knodell histology activity index and beyond
14. Which patients with hepatitis C develop liver complications?
15. Hepatitis C: Somber views of natural history and optimistic views of interferon treatment?
16. Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption
17. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?
18. The long-term pathological evolution of chronic hepatitis C
19. Histopathology of chronic hepatitis C in relation to epidemiological factors
20. Pruritus in chronic hepatitis C: Association with high serum bile acids, advanced pathology and bile duct abnormalities
21. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
22. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
23. Relationship of aminotransferases to liver histological status in chronic hepatitis C
24. Liver histology in hepatitis C infection: A comparison between patients with persistently normal or abnormal transaminases
25. Clinicopathological assessment of hepatitis C virus infection in parenteral drug abusers
26. Do alanine aminotransferase reflect histological status in chronic HCV infection?
27. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease
28. Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels
29. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatits
30. Correlation of viral RNA, alanine aminotransferase, and histopathology in hepatitis C virus-associated hepatitis
31. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
32. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection
33. Non-invasive assessment of inflammatory activity and fibrosis (grade and stage) in chronic hepatitis C infection